Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma A...(use the new SAFE Product Certification P...),Health

"As the first technology vendor to have a product certified by SAFE, Aladdin enjoys a leading role in providing strong authentication technologies to some of the most security-minded organizations in the industry," said Chen Arbel, vice president of strategic development at Aladdin. "By creating the keys on board the Aladdin eToken, we ensure the protection of data and prevent forgery in an industry that demands a consistent, secure method of confirming identities."

Aladdin eToken provides strong authentication for the pharmaceutical industry worldwide, meeting regulations such as those surrounding the European Union SSCD (Secure Signature Creation Device) that requires digital signatures to be hosted on a secure signature creation device such as Aladdin eToken.

About SAFE-BioPharma Association

SAFE-BioPharma Association is the non-profit association that created and manages the SAFE(TM) digital identity and digital signature standard for the pharmaceutical and healthcare industries. Through the SAFE standard, the association promotes interoperability and integration among researchers, vendors, regulators, clinicians and other pharmaceutical and healthcare stakeholders. The SAFE standard provides a secure, enforceable, and regulatory compliant way to verify the identities of parties involved in business-to-business and business-to-regulator electronic transactions. SAFE stands for "Signatures and Authentication For Everyone." The Association's members include Amgen, AstraZeneca, Bristol-Myers Squibb, Genzyme, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer, Procter & Gamble, Roche and Sanofi-Aventis. For more information, visit